Ram Nagaraj, PhD, professor of ophthalmology at the University of Colorado School of Medicine and chief scientific advisor for EyeGenex, has obtained new patents in the pursuit of pioneering drugs for glaucoma and diabetic retinopathy to prevent blindness.